The million women study: A critique

Endocrine

Volumn 24, Issue 3, 2004, Pages 187-193

  Whitehead, Malcolm ^a   Farmer, Richard ^b  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Breast cancer; HRT; Million Women Study

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; GESTAGEN; TIBOLONE;

BREAST CANCER; CANCER RISK; HEALTH PRACTITIONER; HORMONE SUBSTITUTION; HUMAN; MENOPAUSAL SYNDROME; METHODOLOGY; PRIORITY JOURNAL; REVIEW; SCIENTIFIC LITERATURE; UNITED KINGDOM; ARTICLE; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; EPIDEMIOLOGY; ESTROGEN THERAPY; FEMALE; MAMMOGRAPHY; MIDDLE AGED; RADIOGRAPHY; SENSITIVITY AND SPECIFICITY; WOMEN'S HEALTH;

BIAS (EPIDEMIOLOGY); BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; GREAT BRITAIN; HUMANS; MAMMOGRAPHY; MIDDLE AGED; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY; WOMEN'S HEALTH;

EID: 16644391399     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1385/ENDO:24:3:187     Document Type: Review

References (30)

1. Beral, V. and Million Women SC. (2003). Lancet 362, 419-427.
2. The Million Women Study Collaborative Group. (1999). Breast Cancer Research 1, 73-80.
3. Banks, E., Beral, V., Cameron, R., et al. (2001). J. Epidemiol. Biostat. 6, 357-363.
4. Vandenbroucke, J. P., van Leeuwen, F. E., and Helmerhorst, F. M. (2003). Nederlands Tijdschrift voor Geneeskunde 147, 1829-1834.
5. Doren, M. (2003). Maturitas 46, 93-94.
6. Lagro-Janssen, T., Rosser, W. W., and van Weel, C. (2003). Lancet 362, 414-415.
7. Garton, M. (2003). Lancet 362, 1328, (author's reply) 1330-1331.
8. Bliss, J. M. and Gray, R. (2003). Lancet 362, 1328-1329.
9. Bundred, N. J. and Morris, J. (2003). Lancet 362, 1329, (author's reply) 1330-1331.
10. Van Leeuwen, F. E. and Rookus, M. A. (2003). Lancet 362, 1330-1331.
11. Braendle, W. (2003). Maturitas 46, 101-102.
12. Patnick, J. (2003). Breast Screening Programme, England, 2002-2003.
13. Bromley, S. E., de Vries, C. S., and Farmer, R. D. (2004). BJOG 111, 369-376.
14. Speroff, L. (2003). Maturitas 46, 1-6.
15. Hill, A. B. (1965). Proc. R. Soc. Med. 58, 295-300.
16. Collaborative Group on Hormonal Factors in Breast Cancer. (1997). Lancet 350, 1047-1059.
17. Rossouw, J. E., Anderson, G. L., Prentice, R. L., et al., Writing Group for the Women's Health Initiative Investigators. (2002). JAMA 288, 321-333.
18. Chlebowski, R. T., Hendrix, S. L., Langer, R. D., et al., Investigators WHI. (2003). JAMA 289, 3243-3253.
19. Beral, V., Banks, E., and Reeves, G. (2002). Lancet 360, 942-944.
20. Beral, V., Banks, E., Reeves, G., and Appleby, P. (1999). J. Epidemiol. Biostat. 4, 191-210.
21. Bergkvist, L., Adami, H. O., Persson, I., Hoover, R., and Schairer, C. (1989). N. Engl. J. Med. 321, 293-297.
22. Magnusson, C., Baron, J. A., Correia, N., Bergstrom, R., Adami, H. O., and Persson, I. (1999). Int. J. Cancer 81, 339-344.
23. Schairer, C., Lubin, J., Troisi, R., Sturgeon, S., Brinton, L., and Hoover, R. (2000). JAMA 283, 485-491.
24. Ross, R. K., Paganini-Hill, A., Wan, P. C., and Pike, M. C. (2000). J. Natl. Cancer Inst. 92, 328-332.
25. Li, C. I., Malone, K. E., Porter, P. L., et al. (2003). JAMA 289, 3254-3263.
26. Bush, T. L., Whiteman, M., and Flaws, J. A. (2001). Obstet. Gynecol. 98, 498-508.
27. Anderson, G. L., Limacher, M., Assaf, A. R., et al., Women's Health Initiative Steering Committee. (2004). JAMA 291, 1701-1712.
28. Kopernik, G. and Shoham, Z. (2004). Fertil. Steril. 81, 1458-1477.
29. Heuser, L., Spratt, J. S., and Polk, H. C. Jr. (1979). Cancer 43, 1888-1894.
30. Gullino, P. M. (1977). Cancer 39, Suppl.-703.